Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion.
about
Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition by new glucocortico ...... 1, IL-8, and RANTES secretion.
@en
Inhibition by new glucocortico ...... 1, IL-8, and RANTES secretion.
@nl
type
label
Inhibition by new glucocortico ...... 1, IL-8, and RANTES secretion.
@en
Inhibition by new glucocortico ...... 1, IL-8, and RANTES secretion.
@nl
prefLabel
Inhibition by new glucocortico ...... 1, IL-8, and RANTES secretion.
@en
Inhibition by new glucocortico ...... 1, IL-8, and RANTES secretion.
@nl
P2093
P2860
P356
P1476
Inhibition by new glucocortico ...... 1, IL-8, and RANTES secretion.
@en
P2093
Henry J Lee
Leeshawn D Thomas
Thomas C S Keller
Younes J Errahali
P2860
P304
P356
10.1089/JIR.2012.0129
P577
2013-05-16T00:00:00Z